The first FDA-approved, CLIA-waived rapid HCV test
The OraQuick® HCV test is FDA approved for detecting HCV antibodies in fingerstick and venipuncture whole blood. Our simple platform enables healthcare providers to deliver an accurate diagnosis in 20 minutes.
Clinically proven performance, OraQuick® HCV is greater than 98% accurate.
Appropriate For Testing In:
OraQuick® is CLIA-waived and is appropriate for testing in locations such as:
Public Health Settings
Key Product Features:
Point-of-care testing results in 20 minutes
Greater than 98% accurate
Tests for multiple HCV genotypes
Fingerstick and venipuncture whole blood collection